Related references
Note: Only part of the references are listed.The Pathogenesis of the Antiphospholipid Syndrome
Bill Giannakopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study
Savino Sciascia et al.
INFLAMMATION RESEARCH (2012)
Identification of Fibrin Clot-Bound Plasma Proteins
Simone Talens et al.
PLOS ONE (2012)
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism
Marek Zolcinski et al.
THROMBOSIS AND HAEMOSTASIS (2012)
A history of early stent thrombosis is associated with prolonged clot lysis time
Oksana Pankiw-Bembenek et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (OMEGA-PCI Clot)
Grzegorz Gajos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Fibrin Clot Structure and Function A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases
Anetta Undas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment
A. Tripodi et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
Neurological manifestations of antiphospholipid syndrome
Carlos E. M. Rodrigues et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
Masahiro Ieko et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Antiphospholipid syndrome
Guillermo Ruiz-Irastorza et al.
LANCET (2010)
The Antiphospholipid Syndrome as a Neurological Disease
Yoav Arnson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis
Beata Kwasny-Krochin et al.
THROMBOSIS RESEARCH (2010)
Impaired Fibrinolysis in the Antiphospholipid Syndrome
Katie A. Krone et al.
Current Rheumatology Reports (2010)
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
R. A. Ajjan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
β2-Glycoprotein I Is a Cofactor for Tissue Plasminogen Activator-Mediated Plasminogen Activation
Chunya Bu et al.
ARTHRITIS AND RHEUMATISM (2009)
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives
Anetta Undas et al.
BLOOD (2009)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Heritability of Clot Formation
Kristina F. Standeven et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke
Anetta Undas et al.
STROKE (2009)
Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress
Anetta Undas et al.
ATHEROSCLEROSIS (2008)
Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis
P. P. Chen et al.
LUPUS (2008)
Cardiac manifestations in antiphospholipid syndrome
Pal Soltesz et al.
AUTOIMMUNITY REVIEWS (2007)
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis
J. P. Collet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease
A Undas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients
M Cugno et al.
BLOOD (2004)
Antiphospholipid syndrome: multiple mechanisms
CG Mackworth-Young
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Nicked β2-glycoprotein I:: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis
S Yasuda et al.
BLOOD (2004)
Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin
CD Yang et al.
JOURNAL OF IMMUNOLOGY (2004)
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease
JD Mills et al.
CIRCULATION (2002)
Share Paper
